For many cancer survivors, the “all-clear” from an oncologist is a bittersweet victory. While the scans show no evidence of disease, the body often tells a different story—one of profound, crushing fatigue that makes basic daily tasks feel like climbing a mountain. For decades, this “cancer-related fatigue” has been a clinical ghost: felt deeply by … Read more
For decades, the fight against colorectal cancer has focused primarily on the tumor cells themselves. However, the real battle is often won or lost in the “neighborhood”—the complex tumor microenvironment (TME) that can either stifle a cancer’s growth or act as a protective shield against treatment. A groundbreaking study published in the journal Gut suggests … Read more
For patients facing high-grade neuroendocrine tumors (NETs), the medical landscape has long been defined by a stark reality: limited options and a devastatingly aggressive disease progression. However, a new clinical trial at the Sylvester Comprehensive Cancer Center is attempting to rewrite this narrative by shifting the strategy from systemic toxicity to precision immunotherapy. Key Takeaways: … Read more
A significant leap forward in cancer treatment has been demonstrated by researchers at Johns Hopkins University and the University of Maryland School of Pharmacy. Their development of novel drugs targeting hypoxia-inducible factors 1 and 2 (HIF-1/2) – often called “master regulators” of cancer – has shown the potential for complete tumor elimination in mice when … Read more
The Dawn of Functional Cures: How Epstein-Barr Virus Research is Redefining Cancer Treatment Nearly 95% of the global population carries the Epstein-Barr virus (EBV), often without knowing it. For most, it’s a harmless childhood infection. But for a significant minority, EBV is a lifelong threat, linked to a spectrum of cancers, including the aggressive follicular … Read more
The Dawn of Personalized Pancreatic Cancer Treatment: Why Preoperative Therapy is Rewriting the Rules Pancreatic cancer, a disease notorious for its aggressive nature and limited treatment options, is facing a potential turning point. While historically diagnosed at late stages, recent studies – including those from UCLA Health and the Mayo Clinic – demonstrate that administering … Read more
The search for effective Alzheimer’s treatments has long been plagued by incremental progress and limited clinical benefit. Now, a new study published in Proceedings of the National Academy of Sciences signals a potentially paradigm-shifting approach: repurposing CAR-T cell therapy – a technology that has revolutionized cancer treatment – to target the amyloid plaques at the … Read more
Multiple Myeloma: Advances in Treatment Offer Hope for Extended Lifespans Recent breakthroughs in the understanding and treatment of multiple myeloma are significantly improving patient outcomes, offering longer lives and enhanced quality of life. From innovative therapies like CAR-T cell therapy to targeted agents like belantamab mafodotin, the landscape of myeloma treatment is rapidly evolving. Understanding … Read more
CAR T-Cell Therapy Shows Promise for Pediatric Autoimmune Diseases In a significant breakthrough for young patients battling severe autoimmune conditions, a new case series demonstrates the feasibility, safety, and effectiveness of autologous anti-CD19 CAR T-cell therapy. The findings, impacting children with systemic lupus erythematosus, dermatomyositis, and systemic sclerosis, offer a potential new avenue for treatment … Read more
A potential turning point in the fight against Parkinson’s disease has emerged from research at the Institut de Neurociències of the UAB. Scientists have identified a key mechanism driving the loss of dopamine-producing neurons – the hallmark of the disease – and, crucially, demonstrated that immunotherapy could offer a protective effect. This isn’t just another … Read more